Red Light Holland Reports Second Quarter 2021 Results
Company announces 56% increase in the number of stores selling its iMicrodose products in the NetherlandsSix-month revenues of $1,080,875Toronto, Ontario--(News... Read More...
SUBSCRIBE NOW
Join our
subscribers!
Financials
Financial reporting
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
Multistate expansion underway, signed LOI to acquire Arizona-based mental health practiceTotal revenue of $1,857,750, +113% when compared to same period last ye... Read More...
Psyence Group Inc. files Q2 Unaudited Condensed Consolidated Interim Financial Statements and MD&A
TORONTO, Nov. 26, 2021 -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company with a focus on natur... Read More...
Mydecine Reports Third Quarter 2021 Financial Results and Provides Business Update
--To Launch Phase 2/3 Smoking Cessation Clinical Trial with Johns Hopkins University (JHU) Signed 5-Year Research Agreement with JHU to Further Mydecine’s Resea... Read More...
Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update
Announced plans to advance FT-104, its novel psychedelic compound, to clinic for Treatment-Resistant Depression and Postpartum Depression as the lead indication... Read More...
Cybin Inc. Reports its Second Quarter Financial Results and Recent Business Highlights
- Company to host conference call at 4:30pm EST today –TORONTO, November 15, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "... Read More...
Silo Pharma Reports Third Quarter Results and Operating Highlights
Englewood Cliffs, NJ, Nov. 11, 2021 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a th... Read More...
Cybin to Announce Second Quarter FY2021 Financial Results and Business Update on November 15, 2021
TORONTO, November 09, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progr... Read More...
COMPASS Pathways plc to announce third quarter 2021 financial results on 9 November 2021
London, U.K., Nov. 08, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based inno... Read More...
Novamind Reports FY2021 Financial Results and Operating Highlights
Industry-leading revenue, $6,069,247 in FY2021Total working capital of $9,680,431 to fund operationsExpanded network to six clinics and three clinical researc... Read More...
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychede... Read More...
Aion Therapeutic Files Financials
Toronto, Ontario--(Newsfile Corp. - November 2, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing a default status re... Read More...
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET
TORONTO, Nov. 02, 2021 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedel... Read More...
PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022
TORONTO, Oct. 27, 2021 -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, to... Read More...
MINDCURE Announces Financial Results for the First Quarter of Fiscal 2022
VANCOUVER, BC, Oct. 26, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology and researc... Read More...
PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021
TORONTO, Sept. 07, 2021 -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, t... Read More...
MINDCURE Announces Financial Results for Fiscal 2021
VANCOUVER, BC, Aug. 31, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology and researc... Read More...
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
At June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investmentsDevelopment of FT-104, ... Read More...
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0, its Digital Health Platform to Support the... Read More...
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
Highlights:Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021Partne... Read More...
Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET
TORONTO, Aug. 10, 2021 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedel... Read More...
COMPASS Pathways plc to announce second quarter 2021 financial results on 11 August 2021
London, UK, Aug. 04, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innova... Read More...
Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements
Toronto, Ontario--(Newsfile Corp. - July 30, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland"), an Ontario-based co... Read More...
Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology
VANCOUVER, BC, July 29, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-b... Read More...
Cybin Inc. Releases Annual Financials and Provides Business Highlights
TORONTO, June 28, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychede... Read More...
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results
Field Trip completes FY2021 as the largest vertically integrated psychedelics company positioned to be a leader in the emerging industryContinues to leverage it... Read More...
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET
TORONTO, June 17, 2021 -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedel... Read More...
New Wave Holdings subsidiary, Way of Will Inc. is pleased to announce its launch of high-quality mushroom products for Q1 2021
TORONTO, Jan. 14, 2021 - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital... Read More...
Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019
VANCOUVER, BC, Jan. 7, 2021 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a di... Read More...
Cybin Announces First Quarter Financial Results of Clarmin Explorations Inc.
Cybin Inc. (NEO:CYBN) ("Cybin"), a life sciences company focused on psychedelic pharmaceutical therapies, announces the unaudited financial results of Clarmin E... Read More...
Red Light Holland Announces Intention to Acquire Controlling Interest in Psychedelic Insights Providing Psychological Guidance of Psychedelic Experiences with Truffles in the Netherlands
Toronto, Ontario--(Newsfile Corp. - December 9, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland") is pleased to announce... Read More...
Empower Reports Q3 2020 Results With 67% Revenue Increase for The Nine Months Ended September 30, 2020
VANCOUVER, BC / ACCESSWIRE / November 25, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTC PINK:EPWCF) (Frankfurt:8EC) ("Empower") has filed today its unaudited cond... Read More...
Mydecine Innovations Group to Restate Financial Statements
VANCOUVER, British Columbia, Nov. 24, 2020 -- Mydecine Innovations Group Inc. (the “Company”) (CSE:MYCO | OTC:MYCOF) announces that its previously issued financ... Read More...
MindMed Announces Q3 2020 Financial Results;
Cash Reserves Total $37.8 million USD ($50.1 million CAD) Post October FinancingTORONTO, Nov 13, 2020 -- MindMed (NEO: MMED) (OTCQB: MMEDF), a leading psychedel... Read More...
Hollister Biosciences Inc. Provides Update on Q3 2020 Performance
VANCOUVER, BC, Oct. 27, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a d... Read More...
Thoughtful Brands Inc. Announces Q2 2020 Highlights
An eCommerce company specializing in natural health products chronicles latest revenue, strategic acquisitions and partnerships, expansion and trajectoryVANCOUV... Read More...
Empower Clinics Reports Q2 2020 Results with 56% Revenue Increase and YTD 2020 with 130% Revenue Increase
VANCOUVER, BC / ACCESSWIRE / August 25, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF) (Frankfurt:8EC) ("Empower" or the "Company") has filed today its una... Read More...
Hollister Biosciences Inc. Reports Second Quarter 2020 Results
Multi-state operator and diversified cannabis branding company generates record quarterly revenue and delivers profitable second quarterVANCOUVER, BC, Aug. 24, ... Read More...
Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results
NEW YORK, Aug. 14, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has announced its second quart... Read More...
Empower Clinics Reports Q1 2020 Results with 416% Revenue Increase
VANCOUVER, BC / ACCESSWIRE / July 28, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTCQB:EPWCF) (Frankfurt:8EC)("Empower" or the "Company") has filed today its unaud... Read More...
Make smarter
investment strategies
with in-depth news reports
Join our subscribers!
By subscribing, you agree to our
Terms and Conditions
We don't spam and we promise to never share your information.